Changes in HIV-Related Cervical Cancer Over a Decade in Côte d'Ivoire

Autor: Didier K. Ekouevi, Isidore Diomande, Judith Didi-Kouko Coulibaly, Kouassi Comoe, Boris Tchounga, Innocent Adoubi, Simon Boni, Apollinaire Horo, Antoine Jaquet, Aristophane Tanon
Přispěvatelé: Bordeaux population health (BPH), Université de Bordeaux (UB)-Institut de Santé Publique, d'Épidémiologie et de Développement (ISPED)-Institut National de la Santé et de la Recherche Médicale (INSERM), Université Félix Houphouët-Boigny (UFHB), Université de Lomé [Togo]
Rok vydání: 2021
Předmět:
Cancer Research
medicine.medical_specialty
Invasive cervical cancer
Human immunodeficiency virus (HIV)
Uterine Cervical Neoplasms
HIV Infections
[SDV.CAN]Life Sciences [q-bio]/Cancer
Cote d ivoire
[SDV.MHEP.GEO]Life Sciences [q-bio]/Human health and pathology/Gynecology and obstetrics
medicine.disease_cause
03 medical and health sciences
0302 clinical medicine
Pregnancy
[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases
medicine
Humans
030212 general & internal medicine
Cervical cancer
Gynecologic Cancer
Obstetrics
business.industry
ORIGINAL REPORTS
medicine.disease
CD4 Lymphocyte Count
3. Good health
Cote d'Ivoire
Cross-Sectional Studies
Oncology
030220 oncology & carcinogenesis
Female
[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie
business
Zdroj: JCO Global Oncology
JCO Global Oncology, American Society of Clinical Oncology, 2021, 7, pp.782-789. ⟨10.1200/go.21.00006⟩
ISSN: 2687-8941
DOI: 10.1200/go.21.00006
Popis: PURPOSE Major improvements have occurred in access to invasive cervical cancer (ICC) screening in HIV-infected women over the past decade in sub-Saharan Africa. However, there is limited information on changes in the burden of HIV-related ICC at a population level. Our objective was to compare HIV-related ICC over a decade and document factors associated with HIV infection in women with ICC in Côte d'Ivoire. METHODS A repeated cross-sectional study was conducted in referral hospitals of Abidjan, Côte d'Ivoire, through the 2009-2011 and 2018-2020 periods. Women diagnosed with ICC were systematically tested for HIV. Demographics, ICC risk factors, cancer stage (International Federation of Gynecology and Obstetrics), and HIV characteristics were collected through questionnaires. Characteristics of HIV-related ICC were compared between the periods, and factors associated with HIV in women diagnosed with ICC in 2018-2020 were documented through a multivariable logistic model. RESULTS During the 2009-2011 and 2018-2020 periods, 147 and 297 women with ICC were diagnosed with estimated HIV prevalence of 24.5% and 21.9% ( P = .53), respectively. In HIV-infected women, access to antiretroviral treatment increased from 2.8% to 73.8% ( P < 10−4) and median CD4 cell count from 285 (IQR, 250-441) to 492 (IQR, 377-833) cells/mm3 ( P = .03). In women diagnosed with ICC during the 2018-2020 period, HIV infection was associated with a less advanced clinical stage (International Federation of Gynecology and Obstetrics I or II stage) (adjusted OR, 2.2 [95% CI, 1.1 to 4.4]) and with ICC diagnosis through a systematic screening (adjusted OR, 10.5 [95% CI, 2.5 to 45.5]). CONCLUSION Despite a persistently high proportion of HIV-related ICC over time in Côte d'Ivoire, HIV was associated with less advanced clinical stage at ICC diagnosis. Recent improvements in ICC screening services across HIV clinics might explain this association and support their implementation across non-HIV health facilities.
Databáze: OpenAIRE